|  | LRC (%) | p | DMFS (%) | p | DFS (%) | p | DSS (%) | p | OS (%) | p |
---|---|---|---|---|---|---|---|---|---|---|---|
Stage | I-II III-IV | 81.8 66.4 | 0.245 | 84.6 77.5 | 0.548 | 69.2 55.1 | 0.282 | 76.9 60.4 | 0.208 | 76.9 54.2 | 0.033 |
T stage | T1-2 T3-4 | 77.5 61.6 | 0.145 | 81.9 75.6 | 0.458 | 66.3 49.6 | 0.139 | 71.3 55.9 | 0.144 | 66.7 50.4 | 0.021 |
N stage | N0-1 N2-3 | 74.1 62.2 | 0.196 | 87.5 66.8 | 0.023 | 66.7 45.8 | 0.024 | 75.8 46.6 | 0.007 | 72.3 40.0 | 0.002 |
Depth (millimeters) | ≤10 > 10 | 61.2 74.8 | 0.367 | 90.0 71.7 | 0.118 | 55.1 58.8 | 0.938 | 67.9 60.3 | 0.694 | 62.4 55.1 | 0.417 |
Differentiation | Well Moderate Poor | 72.0 67.1 75.0 | 0.818 | 86.6 82.5 37.5 | 0.003 | 66.0 56.6 37.5 | 0.264 | 70.2 64.1 37.5 | 0.203 | 66.7 56.8 37.5 | 0.580 |
Nodal ECS | No Yes | 78.1 53.8 | 0.049 | 87.9 63.7 | 0.019 | 70.7 38.3 | 0.005 | 79.5 39.4 | 0.001 | 75.6 34.3 | 0.001 |
Skin invasion | No Yes | 71.6 41.7 | 0.153 | 81.3 51.4 | 0.076 | 60.5 28.6 | 0.071 | 67.0 28.6 | 0.033 | 60.8 28.6 | 0.204 |
Bone invasion | No Yes | 71.6 62.7 | 0.407 | 74.5 90.7 | 0.226 | 57.7 56.9 | 0.871 | 64.2 60.2 | 0.940 | 58.9 54.8 | 0.251 |
Perineural invasion | No Yes | 68.1 71.9 | 0.717 | 81.3 69.2 | 0.295 | 58.6 51.9 | 0.349 | 67.8 50.0 | 0.170 | 62.0 45.8 | 0.318 |
Blood vessel invasion | No Yes | 67.5 80.0 | 0.729 | 78.0 75.0 | 0.999 | 56.0 60.0 | 0.891 | 62.4 60.0 | 0.909 | 56.6 60.0 | 0.741 |
Lymphatic vessel invasion | No Yes | 67.6 75.8 | 0.845 | 81.9 55.6 | 0.014 | 58.1 46.3 | 0.218 | 65.1 45.8 | 0.106 | 59.6 41.7 | 0.117 |
Margin status (millimeters) | ≥ 5 < 5 | 67.1 80.8 | 0.406 | 77.3 84.6 | 0.737 | 55.4 68.4 | 0.517 | 59.2 83.3 | 0.152 | 54.1 65.9 | 0.157 |
Concurrent chemotherapy | No Yes | 70.8 67.8 | 0.613 | 89.3 66.0 | 0.014 | 65.2 48.9 | 0.071 | 72.6 52.4 | 0.506 | 70.6 44.3 | 0.022 |
GP96 overexpression | No Yes | 90.2 58.7 | 0.008 | 95.8 69.5 | 0.018 | 86.5 44.7 | 0.001 | 95.7 49.0 | 0.001 | 87.5 44.9 | 0.003 |